Summary
The market is in decline, ALL major generic companies already have the product.. the only way for Aurobindo to get market share is to undercut the competition. With little margin already, not a money spinner.
Analysis
terbinafine |
12 mo Ending | 12 mo Ending | % Change | 12 mo Ending | 12 mo Ending | % Change |
| 6/30/2008 | 6/30/2007 | 6/30/2008 | 6/30/2007 | |||
| USA: |
89M |
680M |
-86.9% |
20,758.9 kg |
18,994.1 kg |
9.3% |
| EU: |
245.8M |
285.7M |
-14% |
40,603.2 kg |
41,721.9 kg |
-2.7% |
| Rest of Europe: |
42.4M |
37.1M |
14.3% |
4,295.9 kg |
4,186.7 kg |
2.6% |
| Rest of World: |
418.9M |
399.4M |
4.9% |
50,410.7 kg |
44,679.7 kg |
12.8% |
| Worldwide: |
796M |
1402.1M |
-43.2% |
116,068.7 kg |
109,582.4 kg |
5.9% |
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
